Central Plains Bancshares, Inc. Common Stock
NASDAQ:CPBIShell Companies
-$0.18 today
- Market cap
- $85.57M
- Beta
- 0.21
- P/E (TTM)
- 18.0
- EPS (TTM)
- $1.03
Volume 0.00M
Average 0.00M
CPBI EBITDA Margin
EBITDA as a percentage of revenue.
Central Plains Bancshares, Inc. Common StockNASDAQ: CPBI
EBITDA Margin · Q3 FY2025 · quarter ended Dec 2025
EBITDA Margin widens to 22.0%
EBITDA Margin was 22.0% in Q3 FY2025, up 2.9 pp from a year earlier. On a trailing-twelve-month basis it was 19.2%, up 0.1 pp year over year. Over 3 fiscal years it narrowed by 8.8 pp.
Context
- EBITDA Margin widened in 1 of the last 3 fiscal years.
What to watch
Whether EBITDA Margin reaches the consensus estimate from 1 analysts of 20.1% for the fiscal year ending Mar 2026, up from 18.2% in FY2024.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterDec 2025
- 22.0%+3.3 pp QoQ
- Last fiscal yearMar 2025
- 18.2%-3.4 pp YoY
- LTMDec 2025
- 19.2%+0.1 pp YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +2.9 pp | — | — |
| 1 year | -3.4 pp | +1.8 pp | +5.3 pp |
| 3 years | -8.8 pp | — | — |
| 5 years | — | — | |
| 10 years | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA Margin history
Percent of revenue · from the income statement
- Latest · FY2024
- 18.2%
- Year-over-year change
- -3.4pp
| Period | Period end | EBITDA Margin | YoY change |
|---|---|---|---|
| FY2024 | 2025-03-31 | 18.2% | -3.4pp |
| FY2023 | 2024-03-31 | 21.6% | +8.3pp |
| FY2022 | 2023-03-31 | 13.4% | -13.7pp |
| FY2021 | 2022-03-31 | 27.0% | — |
EBITDA Margin vs competitors
How CPBI compares with its peers on the latest reported figures
- CPBI's LTM Dec 2025 EBITDA Margin of 19.2% is the 2nd highest of the 4 companies compared; the peer median is 18.1%.
- Its year-over-year change of +0.1 pp is the 2nd highest of 4, against a peer median of -0.2 pp.
- Over three fiscal years its change of -8.8 pp compares with a peer median of -9.3 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Mar 2026 | 93.0% | -0.2 pp | +17.6 pp | |
| LTM Dec 2025 | 19.2% | +0.1 pp | -8.8 pp | |
| LTM Mar 2026 | 18.1% | +1.0 pp | -11.1 pp | |
| LTM Mar 2026 | 15.3% | -4.2 pp | -9.3 pp | |
ORIQUOrigin Investment Corp I Units | FY2025 | — | — | — |
| FY2025 | — | — | — | |
AFJKAimei Health Technology Co., Ltd | FY2025 | — | — | — |
| FY2025 | — | — | — | |
| Peer median (excluding CPBI) | 18.1% | -0.2 pp | -9.3 pp | |
Competitors are the stored peer set for CPBI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Mar 2022 | FY2022 Mar 2023 | FY2023 Mar 2024 | FY2024 Mar 2025 |
|---|---|---|---|---|
| Revenue | 15.68M | 18.42M | 23.82M | 27.31M |
| Cost of Revenue | 965K | 5.62M | 6.58M | 8.41M |
| Gross Profit | 14.71M | 12.8M | 17.24M | 18.9M |
| Gross Margin | 93.8% | 69.5% | 72.4% | 69.2% |
| Research & Development | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 6.65M | 6.18M | 7.47M | 8.49M |
| Operating Expenses | 10.97M | 10.84M | 12.6M | 14.38M |
| Depreciation & Amortization | 497K | 503K | 518K | 455K |
| EBITDA | 4.24M | 2.47M | 5.15M | 4.98M |
| EBITDA Margin | 27.0% | 13.4% | 21.6% | 18.2% |
| Operating Income | 3.74M | 1.96M | 4.64M | 4.52M |
| Operating Margin | 23.9% | 10.7% | 19.5% | 16.6% |
| Interest Income | 13.17M | 16.14M | 20.96M | 24.7M |
| Interest Expense | 1.08M | 2.74M | 6.49M | 8.21M |
| Other Income / Expenses | 0 | 0 | 0 | 0 |
| Income Before Tax | 3.74M | 1.96M | 4.64M | 4.52M |
| Pre-Tax Margin | 23.9% | 10.7% | 19.5% | 16.6% |
| Income Tax Expense | 595K | 317K | 877K | 869K |
| Net Income | 3.15M | 1.65M | 3.76M | 3.65M |
| Net Margin | 20.1% | 8.9% | 15.8% | 13.4% |
| EPS (Basic) | 0.86 | 0.45 | 1.10 | 0.96 |
| EPS (Diluted) | 0.86 | 0.40 | 1.10 | 0.96 |
| Weighted Avg Shares | 3.68M | 3.68M | 3.44M | 3.82M |
| Weighted Avg Shares (Diluted) | 3.68M | 4.13M | 3.44M | 3.82M |
Central Plains Bancshares, Inc. Common Stock
NASDAQ:CPBI
Intrinsic Alpha fair value
Locked
Current Price
$20.51
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.